Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] NLMUID: 0315061"" wg kryterium: JN


Tytuł :
Antimalarial drug candidates in phase I and II drug development: a scoping review.
Autorzy :
Abd-Rahman AN; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Zaloumis S; Biostatistics Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, Victoria, Australia.
McCarthy JS; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and the Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Simpson JA; Biostatistics Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, Victoria, Australia.
Commons RJ; Global Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia.; Internal Medical Services, Ballarat Health Services, Ballarat, Victoria, Australia.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Nov 29, pp. AAC0165921. Date of Electronic Publication: 2021 Nov 29.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Impact of empirical antibiotic regimens on mortality in neutropenic patients with bloodstream infection presenting with septic shock.
Autorzy :
Chumbita M; Department of Infectious Diseases, Hospital Clínic-IDIBAPS, Barcelona, Spain.
Puerta-Alcalde P; Department of Infectious Diseases, Hospital Clínic-IDIBAPS, Barcelona, Spain.
Gudiol C; Department of Infectious Diseases, Hospital Universitari de Bellvitge, IDIBELL (Institut d´Investigació Biomèdica de Bellvitge), University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.; Institut Català d'Oncologia (ICO), Hospital Duran i Reynals, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; REIPI (Spanish Network for Research in Infectious Diseases), Instituto de Salud Carlos III, Madrid, Spain.
Garcia-Pouton N; Department of Infectious Diseases, Hospital Clínic-IDIBAPS, Barcelona, Spain.
Laporte-Amargós J; Department of Infectious Diseases, Hospital Universitari de Bellvitge, IDIBELL (Institut d´Investigació Biomèdica de Bellvitge), University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.; REIPI (Spanish Network for Research in Infectious Diseases), Instituto de Salud Carlos III, Madrid, Spain.
Ladino A; Internal Medicine Department, Hospital Clínic-IDIBAPS, Barcelona, Spain.
Albasanz-Puig A; Department of Infectious Diseases, Hospital Universitari de Bellvitge, IDIBELL (Institut d´Investigació Biomèdica de Bellvitge), University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.; REIPI (Spanish Network for Research in Infectious Diseases), Instituto de Salud Carlos III, Madrid, Spain.
Helguera C; Internal Medicine Department, Hospital de Cabueñes, Gijon, Spain.
Bergas A; Department of Infectious Diseases, Hospital Universitari de Bellvitge, IDIBELL (Institut d´Investigació Biomèdica de Bellvitge), University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
Grafia I; Internal Medicine Department, Hospital Clínic-IDIBAPS, Barcelona, Spain.
Sastre E; Department of Infectious Diseases, Hospital Universitari de Bellvitge, IDIBELL (Institut d´Investigació Biomèdica de Bellvitge), University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
Suárez-Lledó M; Hematology Department, Hospital Clínic-IDIBAPS, Barcelona, Spain.
Durà X; Department of Infectious Diseases, Hospital Universitari de Bellvitge, IDIBELL (Institut d´Investigació Biomèdica de Bellvitge), University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.; REIPI (Spanish Network for Research in Infectious Diseases), Instituto de Salud Carlos III, Madrid, Spain.
Jordán C; Department of Infectious Diseases, Hospital Clínic-IDIBAPS, Barcelona, Spain.
Marco F; Microbiology Department, Centre Diagnòstic Biomèdic. Hospital Clínic, Barcelona, Spain.; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Condom M; Hematology Department, Institut Català d'Oncologia (ICO), Hospital Duran i Reynals, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
Castro P; Medical Intensive Care Unit, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain.
Martínez JA; Department of Infectious Diseases, Hospital Clínic-IDIBAPS, Barcelona, Spain.
Mensa J; Department of Infectious Diseases, Hospital Clínic-IDIBAPS, Barcelona, Spain.
Soriano A; Department of Infectious Diseases, Hospital Clínic-IDIBAPS, Barcelona, Spain.
Carratalà J; Department of Infectious Diseases, Hospital Universitari de Bellvitge, IDIBELL (Institut d´Investigació Biomèdica de Bellvitge), University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.; REIPI (Spanish Network for Research in Infectious Diseases), Instituto de Salud Carlos III, Madrid, Spain.
Garcia-Vidal C; Department of Infectious Diseases, Hospital Clínic-IDIBAPS, Barcelona, Spain.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Nov 29, pp. AAC0174421. Date of Electronic Publication: 2021 Nov 29.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Loss of GdpP function in Staphylococcus aureus leads to β-lactam tolerance and enhanced evolution of β-lactam resistance.
Autorzy :
Poon R; Department of Microbial Pathogenesis, School of Dentistry, University of Maryland, Baltimore, MD, USA.; Institute of Marine and Environmental Technology, Baltimore, MD, USA.
Basuino L; Division of HIV/AIDS, Infectious Diseases and Global Health, Department of Medicine, University of California, San Francisco, San Francisco General Hospital, San Francisco, CA, USA.
Satishkumar N; Department of Microbial Pathogenesis, School of Dentistry, University of Maryland, Baltimore, MD, USA.; Institute of Marine and Environmental Technology, Baltimore, MD, USA.
Chatterjee A; Department of Microbial Pathogenesis, School of Dentistry, University of Maryland, Baltimore, MD, USA.; Institute of Marine and Environmental Technology, Baltimore, MD, USA.
Mukkayyan N; Department of Microbial Pathogenesis, School of Dentistry, University of Maryland, Baltimore, MD, USA.; Institute of Marine and Environmental Technology, Baltimore, MD, USA.
Buggeln E; Division of HIV/AIDS, Infectious Diseases and Global Health, Department of Medicine, University of California, San Francisco, San Francisco General Hospital, San Francisco, CA, USA.
Huang L; Drug Research Unit, Department of Clinical Pharmacy, University of California, San Francisco, San Francisco, CA, USA.
Nair V; Microscopy Unit, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA.
Argudín MA; National Reference Centre for Staphylococcus aureus, Department of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles Universitair Laboratorium Brussel (LHUB-ULB), Université Libre de Bruxelles, Brussels, Belgium.
Datta SK; Bacterial Pathogenesis Unit, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Chambers HF; Division of HIV/AIDS, Infectious Diseases and Global Health, Department of Medicine, University of California, San Francisco, San Francisco General Hospital, San Francisco, CA, USA.
Chatterjee SS; Department of Microbial Pathogenesis, School of Dentistry, University of Maryland, Baltimore, MD, USA.; Institute of Marine and Environmental Technology, Baltimore, MD, USA.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Nov 29, pp. AAC0143121. Date of Electronic Publication: 2021 Nov 29.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Population Pharmacokinetic and Concentration-QTc Analysis of Delamanid in Pediatric Participants with Multidrug-Resistant Tuberculosis.
Autorzy :
Sasaki T; Otsuka Pharmaceutical Co, Ltd, Osaka, Japan.
Svensson EM; Department of Pharmacy, Uppsala University, Uppsala, Sweden.; Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands.
Wang X; Otsuka Pharmaceutical Development & Commercialization, Inc, Rockville, MD, USA.
Wang Y; Otsuka Pharmaceutical Development & Commercialization, Inc, Rockville, MD, USA.
Hafkin J; Otsuka Pharmaceutical Development & Commercialization, Inc, Rockville, MD, USA.
Karlsson MO; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
Mallikaarjun S; Otsuka Pharmaceutical Development & Commercialization, Inc, Rockville, MD, USA.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Nov 29, pp. AAC0160821. Date of Electronic Publication: 2021 Nov 29.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Activity of Oritavancin Against Gram-positive Pathogens Causing Bloodstream Infections in the United States Over 10 Years: Focus on Drug-Resistant Enterococcal Subsets (2010-2019).
Autorzy :
Carvalhaes CG; JMI Laboratories, North Liberty, IA 52317.
Sader HS; JMI Laboratories, North Liberty, IA 52317.
Streit JM; JMI Laboratories, North Liberty, IA 52317.
Castanheira M; JMI Laboratories, North Liberty, IA 52317.
Mendes RE; JMI Laboratories, North Liberty, IA 52317.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Nov 22, pp. AAC0166721. Date of Electronic Publication: 2021 Nov 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Differences in fosfomycin resistance mechanisms between Pseudomonas aeruginosa and Enterobacterales.
Autorzy :
Zheng D; University of Minnesota College of Pharmacy, Minneapolis, Minnesota, USA.
Bergen PJ; Centre for Medicine Use and Safety, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Landersdorfer CB; Centre for Medicine Use and Safety, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Hirsch EB; University of Minnesota College of Pharmacy, Minneapolis, Minnesota, USA.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Nov 22, pp. AAC0144621. Date of Electronic Publication: 2021 Nov 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Organic acids and their salts potentiate the activity of selected antibiotics against Pseudomonas aeruginosa biofilms grown in a synthetic cystic fibrosis sputum medium.
Autorzy :
Bao X; Laboratory of Pharmaceutical Microbiology, Ghent University, Ghent, Belgium.
Bové M; Laboratory of Pharmaceutical Microbiology, Ghent University, Ghent, Belgium.
Coenye T; Laboratory of Pharmaceutical Microbiology, Ghent University, Ghent, Belgium.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Nov 22, pp. AAC0187521. Date of Electronic Publication: 2021 Nov 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Clinical relevance of rifampicin-moxifloxacin interaction in isoniazid resistant/intolerant tuberculosis patients.
Autorzy :
Vogensen VB; University of Groningen, University Medical Center Groningen, department of Pulmonary diseases and Tuberculosis, Groningen, the Netherlands.
Bolhuis MS; University of Groningen, University Medical Center Groningen, department of Clinical Pharmacy and Pharmacology, Groningen, the Netherlands.
Sturkenboom MGG; University of Groningen, University Medical Center Groningen, department of Clinical Pharmacy and Pharmacology, Groningen, the Netherlands.
van der Werf TS; University of Groningen, University Medical Center Groningen, department of Pulmonary diseases and Tuberculosis, Groningen, the Netherlands.
de Lange WCM; University of Groningen, University Medical Center Groningen, department of Pulmonary diseases and Tuberculosis, Groningen, the Netherlands.; University of Groningen, University Medical Center Groningen, TB center Beatrixoord, Groningen, the Netherlands.
Anthony RM; National Institute for Public Health and the Environment, TB reference Laboratory (RIVM), Bilthoven, the Netherlands.
van Soolingen D; National Institute for Public Health and the Environment, TB reference Laboratory (RIVM), Bilthoven, the Netherlands.
Alffenaar JW; Faculty of Medicine and Health, School of Pharmacy, University of Sydney, Sydney, NSW, Australia.; Westmead Hospital, Westmead, NSW, Australia.; Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Sydney, NSW, Australia.
Kerstjens HAM; University of Groningen, University Medical Center Groningen, department of Pulmonary diseases and Tuberculosis, Groningen, the Netherlands.
Akkerman OW; University of Groningen, University Medical Center Groningen, department of Pulmonary diseases and Tuberculosis, Groningen, the Netherlands.; University of Groningen, University Medical Center Groningen, TB center Beatrixoord, Groningen, the Netherlands.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Nov 22, pp. AAC0182921. Date of Electronic Publication: 2021 Nov 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A Phase 1 Study of Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of a First in Human Engineered Cationic Peptide, PLG0206, Intravenously Administered in Healthy Subjects.
Autorzy :
Huang D; Peptilogics, Pittsburgh, Pennsylvania, USA.
Dobbins D; Peptilogics, Pittsburgh, Pennsylvania, USA.
Ghahramani P; Inncelerex, Jersey City, NJ, USA.
Friedland I; Clinical and Regualtory Consulting.
Steckbeck J; Peptilogics, Pittsburgh, Pennsylvania, USA.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Nov 22, pp. AAC0144121. Date of Electronic Publication: 2021 Nov 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
In Vitro Susceptibility of Gram-negative Pathogens to Cefiderocol in Five Consecutive Annual Multinational SIDERO-WT Surveillance Studies (2014-2019).
Autorzy :
Karlowsky JA; IHMA, Schaumburg, Illinois, USA.; Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Hackel MA; IHMA, Schaumburg, Illinois, USA.
Takemura M; Laboratory for Drug Discovery and Disease Research, Shionogi & Co., Ltd., Osaka, Japan.
Yamano Y; Research Planning Department, Shionogi & Co., Ltd., Osaka, Japan.
Roger E; Infectious Disease Drug Development Consulting, LLC. Easton, Connecticut, USA.
Sahm DF; IHMA, Schaumburg, Illinois, USA.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Nov 22, pp. AAC0199021. Date of Electronic Publication: 2021 Nov 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A photoactivable natural product with broad antiviral activity against enveloped viruses including highly pathogenic coronaviruses.
Autorzy :
Meunier T; Univ Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
Desmarets L; Univ Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
Bordage S; Univ Lille, Université de Liège, Université de Picardie Jules Verne, JUNIA, UMRT 1158 BioEcoAgro, Métabolites spécialisés d'origine végétale, F-59000 Lille, France.
Bamba M; Univ Lille, Université de Liège, Université de Picardie Jules Verne, JUNIA, UMRT 1158 BioEcoAgro, Métabolites spécialisés d'origine végétale, F-59000 Lille, France.; UFR Sciences de la Nature, Université Nangui Abrogoua, BP 801 Abidjan 02, Côte d'Ivoire.
Hervouet K; Univ Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
Rouillé Y; Univ Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
François N; Univ Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
Decossas M; Univ Bordeaux, CBMN UMR 5248, Bordeaux INP, F-33600 Pessac, France.
Sencio V; Univ Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
Trottein F; Univ Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
Tra Bi FH; UFR Sciences de la Nature, Université Nangui Abrogoua, BP 801 Abidjan 02, Côte d'Ivoire.
Lambert O; Univ Bordeaux, CBMN UMR 5248, Bordeaux INP, F-33600 Pessac, France.
Dubuisson J; Univ Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
Belouzard S; Univ Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
Sahpaz S; Univ Lille, Université de Liège, Université de Picardie Jules Verne, JUNIA, UMRT 1158 BioEcoAgro, Métabolites spécialisés d'origine végétale, F-59000 Lille, France.
Séron K; Univ Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Nov 22, pp. AAC0158121. Date of Electronic Publication: 2021 Nov 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Tenofovir versus lamivudine followed by tenofovir in severe exacerbation of hepatitis B: a randomized controlled study.
Autorzy :
Lu CM; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; School of Medicine, National Yang Ming University, Taipei, Taiwan.
Cheng JS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; School of Medicine, National Yang Ming University, Taipei, Taiwan.
Sun WC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; School of Medicine, National Yang Ming University, Taipei, Taiwan.
Chen WC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; School of Medicine, National Yang Ming University, Taipei, Taiwan.
Tsay FW; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; School of Medicine, National Yang Ming University, Taipei, Taiwan.
Wang HM; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; School of Medicine, National Yang Ming University, Taipei, Taiwan.
Tsai TJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; School of Medicine, National Yang Ming University, Taipei, Taiwan.
Kao SS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; School of Medicine, National Yang Ming University, Taipei, Taiwan.
Li YD; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; School of Medicine, National Yang Ming University, Taipei, Taiwan.
Li YR; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; School of Medicine, National Yang Ming University, Taipei, Taiwan.
Lin HS; School of Nursing, Fooyin University, Kaohsiung, Taiwan.
Yin CH; Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Tsai WL; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; School of Medicine, National Yang Ming University, Taipei, Taiwan.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Nov 22, pp. AAC0166421. Date of Electronic Publication: 2021 Nov 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Geographic Patterns of Carbapenem-resistant Pseudomonas aeruginosa in the Asia-Pacific Region: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2015-2019.
Autorzy :
Lee YL; Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan, and Institute of Genomics and Bioinformatics, National Chung Hsing University, Taichung, Taiwan.
Ko WC; Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Hsueh PR; Departments of Laboratory Medicine and Internal Medicine, China Medical University Hospital, Taichung, Taiwan.; School of Medicine, China Medical University, Taichung, Taiwan.; Ph.D Program for Aging, School of Medicine, China Medical University, Taichung, Taiwan.; Departments of Laboratory Medicine and Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Nov 22, pp. AAC0200021. Date of Electronic Publication: 2021 Nov 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Assessment of activity and resistance mechanisms to cefepime in combination with the novel β-lactamase inhibitors zidebactam, taniborbactam and enmetazobactam against a multicenter collection of carbapenemase-producing Enterobacterales.
Autorzy :
Vázquez-Ucha JC; Servicio de Microbiología do Complejo Hospitalario Universitario da Coruña (CHUAC), Instituto de Investigación Biomédica da Coruña (INIBIC), Xubias de Arriba, 84, 15006 A Coruña, CIBER de Enfermedades Infecciosas, Spain.
Lasarte-Monterrubio C; Servicio de Microbiología do Complejo Hospitalario Universitario da Coruña (CHUAC), Instituto de Investigación Biomédica da Coruña (INIBIC), Xubias de Arriba, 84, 15006 A Coruña, CIBER de Enfermedades Infecciosas, Spain.
Guijarro-Sánchez P; Servicio de Microbiología do Complejo Hospitalario Universitario da Coruña (CHUAC), Instituto de Investigación Biomédica da Coruña (INIBIC), Xubias de Arriba, 84, 15006 A Coruña, CIBER de Enfermedades Infecciosas, Spain.
Oviaño M; Servicio de Microbiología do Complejo Hospitalario Universitario da Coruña (CHUAC), Instituto de Investigación Biomédica da Coruña (INIBIC), Xubias de Arriba, 84, 15006 A Coruña, CIBER de Enfermedades Infecciosas, Spain.
Álvarez-Fraga L; Servicio de Microbiología do Complejo Hospitalario Universitario da Coruña (CHUAC), Instituto de Investigación Biomédica da Coruña (INIBIC), Xubias de Arriba, 84, 15006 A Coruña, CIBER de Enfermedades Infecciosas, Spain.
Alonso-García I; Servicio de Microbiología, Hospital Provincial Pontevedra, Loureiro Crespo 2, 36002, Pontevedra, Spain.
Arca-Suárez J; Servicio de Microbiología do Complejo Hospitalario Universitario da Coruña (CHUAC), Instituto de Investigación Biomédica da Coruña (INIBIC), Xubias de Arriba, 84, 15006 A Coruña, CIBER de Enfermedades Infecciosas, Spain.
Bou G; Servicio de Microbiología do Complejo Hospitalario Universitario da Coruña (CHUAC), Instituto de Investigación Biomédica da Coruña (INIBIC), Xubias de Arriba, 84, 15006 A Coruña, CIBER de Enfermedades Infecciosas, Spain.
Beceiro A; Servicio de Microbiología do Complejo Hospitalario Universitario da Coruña (CHUAC), Instituto de Investigación Biomédica da Coruña (INIBIC), Xubias de Arriba, 84, 15006 A Coruña, CIBER de Enfermedades Infecciosas, Spain.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Nov 22, pp. AAC0167621. Date of Electronic Publication: 2021 Nov 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Intra-articular vancomycin for the prophylaxis of periprosthetic joint infection caused by methicillin-resistant S. aureus after total knee arthroplasty in a rat model: the dosage, efficacy, and safety.
Autorzy :
Wei J; Division of Joint Surgery and Sports Medicine, Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.; Joint Disease Research Center of Wuhan University, Wuhan, 430071, China.
Tong K; Division of Joint Surgery and Sports Medicine, Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.; Joint Disease Research Center of Wuhan University, Wuhan, 430071, China.
Wang H; Department of pharmacology, Department of basic medicine, Wuhan University, Wuhan, 430071, China.
Wen Y; Division of Joint Surgery and Sports Medicine, Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.; Joint Disease Research Center of Wuhan University, Wuhan, 430071, China.
Chen L; Division of Joint Surgery and Sports Medicine, Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.; Joint Disease Research Center of Wuhan University, Wuhan, 430071, China.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Nov 22, pp. AAC0164121. Date of Electronic Publication: 2021 Nov 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Erratum for Crandon et al., "Comparative Efficacies of Human Simulated Exposures of Telavancin and Vancomycin against Methicillin-Resistant Staphylococcus aureus with a Range of Vancomycin MICs in a Murine Pneumonia Model".
Autorzy :
Crandon JL; Center for Anti-Infective Research and Development, Hartford Hospitalgrid.277313.3, Hartford, Connecticut.
Kuti JL; Center for Anti-Infective Research and Development, Hartford Hospitalgrid.277313.3, Hartford, Connecticut.
Nicolau DP; Center for Anti-Infective Research and Development, Hartford Hospitalgrid.277313.3, Hartford, Connecticut.; Division of Infectious Diseases, Hartford Hospitalgrid.277313.3, Hartford, Connecticut.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Nov 17; Vol. 65 (12), pp. e0187821. Date of Electronic Publication: 2021 Nov 17.
Typ publikacji :
Journal Article; Published Erratum
Czasopismo naukowe
Tytuł :
Erratum for Reitzel et al., "Minocycline-EDTA-Ethanol Antimicrobial Catheter Lock Solution Is Highly Effective In Vitro for Eradication of Candida auris Biofilms".
Autorzy :
Reitzel RA; Department of Infectious Diseases, Infection Control, and Employee Health, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Rosenblatt J; Department of Infectious Diseases, Infection Control, and Employee Health, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Gerges BZ; Department of Infectious Diseases, Infection Control, and Employee Health, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Vargas-Cruz N; Department of Infectious Diseases, Infection Control, and Employee Health, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Raad II; Department of Infectious Diseases, Infection Control, and Employee Health, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Nov 17; Vol. 65 (12), pp. e0198621. Date of Electronic Publication: 2021 Nov 17.
Typ publikacji :
Journal Article; Published Erratum
Czasopismo naukowe
Tytuł :
Erratum for Cumming et al., "Host Bioenergetic Parameters Reveal Cytotoxicity of Antituberculosis Drugs Undetected Using Conventional Viability Assays".
Autorzy :
Cumming BM; Africa Health Research Institute, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.
Baig Z; Africa Health Research Institute, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.
Addicott KW; Africa Health Research Institute, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.
Chen D; Division of Preventive Medicine and Comprehensive Cancer Center, University of Alabama at Birminghamgrid.265892.2, Birmingham, Alabama, USA.
Steyn AJC; Africa Health Research Institute, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.; Department of Microbiology, University of Alabama at Birminghamgrid.265892.2, Birmingham, Alabama, USA.; Centers for AIDS Research and for Free Radical Biology, University of Alabama at Birminghamgrid.265892.2, Birmingham, Alabama, USA.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Nov 17; Vol. 65 (12), pp. e0196821. Date of Electronic Publication: 2021 Nov 17.
Typ publikacji :
Journal Article; Published Erratum
Czasopismo naukowe
Tytuł :
A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus.
Autorzy :
Ganapathy US; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
Del Río RG; Global Health Pharma Unit, GlaxoSmithKline, Tres Cantos, Madrid, Spain.
Cacho-Izquierdo M; Global Health Pharma Unit, GlaxoSmithKline, Tres Cantos, Madrid, Spain.
Ortega F; Global Health Pharma Unit, GlaxoSmithKline, Tres Cantos, Madrid, Spain.
Lelièvre J; Global Health Pharma Unit, GlaxoSmithKline, Tres Cantos, Madrid, Spain.
Barros-Aguirre D; Global Health Pharma Unit, GlaxoSmithKline, Tres Cantos, Madrid, Spain.
Aragaw WW; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
Zimmerman MD; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
Lindman M; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
Dartois V; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.; Department of Medical Sciences, Hackensack Meridian School of Medicine, Nutley, New Jersey, USA.
Gengenbacher M; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.; Department of Medical Sciences, Hackensack Meridian School of Medicine, Nutley, New Jersey, USA.
Dick T; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.; Department of Medical Sciences, Hackensack Meridian School of Medicine, Nutley, New Jersey, USA.; Department of Microbiology and Immunology, Georgetown University, Washington, DC, USA.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Nov 17; Vol. 65 (12), pp. e0151421. Date of Electronic Publication: 2021 Oct 04.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Evolution of Multidrug Resistance in Plasmodium falciparum: a Longitudinal Study of Genetic Resistance Markers in the Greater Mekong Subregion.
Autorzy :
Imwong M; Department of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine, Mahidol Universitygrid.10223.32, Bangkok, Thailand.; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
Suwannasin K; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
Srisutham S; Department of Clinical Microscopy, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, Thailand.
Vongpromek R; Worldwide Antimalarial Resistance Network, Faculty of Tropical Medicine, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
Promnarate C; Worldwide Antimalarial Resistance Network, Faculty of Tropical Medicine, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
Saejeng A; Division of Vector-Borne Diseases, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand.
Phyo AP; Myanmar Oxford Clinical Research Unit, Yangon, Myanmar.
Proux S; Shoklo Malaria Research Unit, Faculty of Tropical Medicine, Mahidol Universitygrid.10223.32, Mae Sot, Thailand.
Pongvongsa T; Savannakhet Provincial Health Department, Savannakhet, Lao People's Democratic Republic.
Chea N; National Center for Parasitology, Entomology, and Malaria Control, Phnom Penh, Cambodia.
Miotto O; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol Universitygrid.10223.32, Bangkok, Thailand.; Wellcome Sanger Institute, Hinxton, United Kingdom.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Tripura R; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol Universitygrid.10223.32, Bangkok, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Nguyen Hoang C; Oxford University Clinical Research Unitgrid.412433.3, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
Dysoley L; National Center for Parasitology, Entomology, and Malaria Control, Phnom Penh, Cambodia.
Ho Dang Trung N; Oxford University Clinical Research Unitgrid.412433.3, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
Peto TJ; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol Universitygrid.10223.32, Bangkok, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Callery JJ; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
van der Pluijm RW; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
Amaratunga C; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol Universitygrid.10223.32, Bangkok, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Mukaka M; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol Universitygrid.10223.32, Bangkok, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
von Seidlein L; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol Universitygrid.10223.32, Bangkok, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Mayxay M; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; Institute of Research and Education Development, University of Health Sciences, Ministry of Health, Vientiane, Lao People's Democratic Republic.; Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospitalgrid.416302.2, Vientiane, Lao People's Democratic Republic.
Thuy-Nhien NT; Oxford University Clinical Research Unitgrid.412433.3, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
Newton PN; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Day NPJ; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol Universitygrid.10223.32, Bangkok, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Ashley EA; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospitalgrid.416302.2, Vientiane, Lao People's Democratic Republic.
Nosten FH; Shoklo Malaria Research Unit, Faculty of Tropical Medicine, Mahidol Universitygrid.10223.32, Mae Sot, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Smithuis FM; Myanmar Oxford Clinical Research Unit, Yangon, Myanmar.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Dhorda M; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol Universitygrid.10223.32, Bangkok, Thailand.; Department of Clinical Microscopy, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
White NJ; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol Universitygrid.10223.32, Bangkok, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Dondorp AM; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol Universitygrid.10223.32, Bangkok, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Nov 17; Vol. 65 (12), pp. e0112121. Date of Electronic Publication: 2021 Sep 13.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies